Pidilite Industries Q1 FY27: Aug 4 results, Q4 snapshot

Overview

Pidilite Industries is set to enter another results cycle with a board meeting lined up to consider its unaudited financials for Q1 FY27 (April to June 2026). The company is widely tracked in the Indian consumer chemicals and construction chemicals space due to its brands in adhesives, sealants and waterproofing. Market participants typically monitor Pidilite for volume growth, pricing actions, input-cost trends and margin direction. Ahead of the announcement, multiple market dashboards also reflect the company’s latest available quarterly numbers as the base reference. Investors also focus on shareholder returns because the company has recently announced dividends and a bonus action in 2025 and a proposed final dividend for FY26.

Board meeting and earnings call schedule

Pidilite’s board meeting is scheduled for 4 August 2026 to consider the unaudited Q1 FY27 financial results. The company’s Q1 FY27 earnings conference call is scheduled for 5 August 2026 at 4:00 p.m. IST. Separately, some result previews had earlier described the Q1 FY27 timing as July to August 2026, pending confirmation, but the schedule referenced here specifies the 4 August board meeting. After the board meeting, the results are typically expected to be available through exchange filings on the BSE and NSE portals.

Latest reported quarter at a glance

The latest earnings snapshot in the provided data points to a quarter with revenue of ₹3,583 crore and net profit of about ₹586 crore, with QoQ and YoY percentage changes also shown on trackers. A detailed quarterly table also lists Total Revenue at ₹3,583.38 crore for the Mar 2026 period, alongside Net Income of ₹579.27 crore and Diluted Normalized EPS of ₹5.74. The same tracker set lists gross profit of ₹735 crore and indicates net profit was down sequentially on a QoQ basis while showing a YoY increase. While different market summaries show small variations in the profit figure, the overall picture presented is that Pidilite exited the March quarter with revenue in the ₹3,500 crore range and profit in the high-₹500 crore range.

Q1 base: June 2025 quarter details

For year-on-year context, the dataset includes consolidated quarterly results for the Jun 2025 period, which forms the comparison base used by some previews for Q1 FY27. In that quarter, Total Revenue was ₹3,753.10 crore, while Operating Income was ₹844.30 crore. Net Income was ₹672.41 crore, and Net Income Before Taxes was ₹916.47 crore. The table also reports Depreciation and amortization of ₹96.68 crore and Diluted Normalized EPS of ₹6.60. These numbers are frequently used by analysts and investors to frame whether the coming quarter is tracking ahead of, in line with, or below last year’s run-rate.

Operating cost and margin signals

The Jun 2025 quarterly table shows Total Operating Expense of ₹2,908.80 crore, which sits against revenue of ₹3,753.10 crore for that period. The same table reports Selling, general and administrative expenses of ₹464.20 crore and Other operating expenses of ₹626.17 crore for Jun 2025. For Mar 2026, the table lists Total Operating Expense of ₹2,855.60 crore, with Operating Income of ₹727.78 crore. The quick details block also references a previous quarter EBITDA margin of 23.4%, while another set of FY26 highlights mentions a Q4 FY26 consolidated EBITDA margin of 23.3%. Taken together, these figures show why the market tends to focus on the company’s cost line and operating leverage each quarter, alongside volume growth and pricing.

Forecast range available from Uniresearch

A results preview in the provided material includes an estimate range for Q1 FY27 based on “Uniresearch trailing-growth projections,” and labels it as subject to change. The preview points to Q1 FY27 revenue of ₹3,942 crore to ₹4,439 crore, compared with Q1 FY26 actual revenue of ₹3,753 crore as the base. It also provides a profit estimate range of ₹708 crore to ₹902 crore versus Q1 FY26 PAT of ₹678 crore. The same preview notes that the Q1 FY27 results are typically declared in July or August and that the results would be published on exchange filing portals after the board meeting.

Dividend and bonus history in the dataset

The corporate action section in the provided data states that Pidilite declared a dividend of ₹10.00 on 13 Aug 2025. It also states that the last bonus declared was on 06 Aug 2025. In FY26 commentary included in the text, the Board is also described as having proposed a final dividend of ₹11.50 per equity share for the financial year ended 31 March 2026, subject to shareholder approval at the 57th AGM, with payment within 30 days of the AGM date. These items are typically tracked alongside quarterly performance because they influence total shareholder return expectations.

Stock snapshot and key ratios

The quick details block lists market capitalisation of ₹165,838.73 crore and a CMP of ₹1,629.4. Another market snapshot in the text shows market cap of ₹160,508 crore and a current price of ₹1,577, reflecting that the displayed values vary by time and source. The same snapshot lists P/E of about 65.2, dividend yield of 0.64%, ROCE of 31.0%, and ROE of 23.9%. These metrics often frame how sensitive the stock can be to small changes in volume growth, margins, or guidance signals.

Key numbers table

What to track next

As Pidilite moves into the Q1 FY27 announcement, investors will primarily look for confirmation of the quarter’s revenue trajectory versus the Jun 2025 base and the Mar 2026 run-rate. The cost line will also matter because the dataset includes both operating expense detail and margin indicators such as EBITDA margin references around the 23% range for Q4 FY26. The earnings call scheduled for 5 August can provide more colour on demand trends across the company’s major categories, including adhesives and waterproofing products that sit within the consumer and bazaar segment referenced in the material. Any update on shareholder return actions, including timelines around proposed dividends, will also remain in focus after the results and AGM-related approvals.